Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
HDAC11 encodes a class IV histone deacetylase.
Showing 10 out of 114 products:
Human Polyclonal HDAC11 Primary Antibody for IHC (p), WB - ABIN387965
Bradbury, Khanim, Hayden, Bunce, White, Drayson, Craddock, Turner: Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. in Leukemia 2005
Show all 4 Pubmed References
Human Polyclonal HDAC11 Primary Antibody for ELISA, ICC - ABIN4316739
Gao, Cueto, Asselbergs, Atadja: Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. in The Journal of biological chemistry 2002
Human Polyclonal HDAC11 Primary Antibody for IHC (p), WB - ABIN387964
Janssen, Schmalbach, Boeselt, Sarlette, Dengler, Petri: Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis. in Journal of neuropathology and experimental neurology 2010
Show all 3 Pubmed References
Overexpressing any of HDAC 3, 6, or 11 suppresses CGG repeat-induced neurodegeneration in a Drosophila model of fragile X tremor ataxia syndrome.
HDAC11 was initially identified as a negative regulator of the well-known anti-inflammatory cytokine IL-10 (show IL10 Antibodies). Hence, antagonizing HDAC11 activity may have anti-tumor potential, whereas activating HDAC11 may be useful to treat chronic inflammation or autoimmunity.
Results showed that the high levels of HDAC11 and lower levels of p53 (show TP53 Antibodies) were detected in pituitary tumor cells. A negative correlation was detected between the data of HDAC11 and p53 (show TP53 Antibodies).
Our study identified a group of cell cycle-promoting genes regulated by HDAC11.
High HDAC11 expression is associated with neoplasms.
Data indicate a pronounced deregulation of HDAC (show HDAC3 Antibodies) genes HDAC9 (show HDAC9 Antibodies) and HDAC11 in patients with Philadelphia-negative chronic myeloproliferative neoplasms: essential thrombocythemia (ET), polycythemia vera (show IGF2BP3 Antibodies) (PV) and primary myelofibrosis (PMF (show PRB1 Antibodies)).
These results demonstrate for the first time that HDAC11 plays an essential role in regulating OX40L (show TNFSF4 Antibodies) expression.
HDAC11 associates with replication origins inhibits Cdt1 (show CDT1 Antibodies)-induced re-replication and suppresses MCM loading.
We found a reduction of HDAC 11 mRNA and increased HDAC 2 (show HDAC2 Antibodies) levels in amyotrophic lateral sclerosis brain and spinal cord compared with controls.
Fluorescence in situ hybridization analysis localized HDAC11 gene to chromosome 3p25, a region characterized by frequent gains and losses of chromosomal material in a number of various types of cancer.
the absence of tumour-specific somatic events in WNT7A (show WNT7A Antibodies) and HDAC11 suggests that these genes are unlikely to have a classical tumour suppressor gene role in sporadic malignant pancreatic endocrine tumours
our results indicate that HDAC11 would suppress myoblast differentiation via regulation of MyoD (show MYOD1 Antibodies)-dependent transcription. These findings suggest that HDAC11 is a novel critical target for controlling myoblast differentiation.
we have been able to demonstrate a lineage-restricted overexpression of HDAC11 in neutrophils and committed neutrophil precursors and it appears to associate with the transcription machinery, possibly regulating the expression of inflammatory and migratory genes in neutrophils. Our results highlight a unique and novel role for HDAC11
our results indicate that the alcohol-induced responsiveness of Kupffer cells to gut (show GUSB Antibodies)-derived endotoxin, in part, is governed by miR (show MLXIP Antibodies)-155 and HDAC11
HDAC11-knockout T cells displayed enhanced proliferation, proinflammatory cytokine production, and effector molecule expression of Eomes and TBX21 transcription factors previously shown to regulate inflammatory cytokine and effector molecule production.
HDAC11 appears to function as a negative regulator of myeloid-derived suppressor cells expansion/function in vivo.
HDAC6 (show HDAC6 Antibodies), primarily a cytoplasmic protein (show BLZF1 Antibodies), associates with HDAC11 and modulates the expression of IL-10 (show IL10 Antibodies) as a transcriptional activator.
The HDAC11 transcript is a PDGF (show PDGFA Antibodies) target; the HDAC11 mRNA abundance correlates inversely with proliferative status.
Male gender and male hormones accelerate kidney ischemia reperfusion-induced decreases in expression and binding of HDAC11, resulting in an increase in PAI-1 (show SERPINE1 Antibodies) expression.
Role for HDAC11 in central nervous system histone deacetylation and the development of oligodendrocytes and neurons during postnatal development.
HDAC11 negatively regulated expression of the gene encoding interleukin 10 (show IL10 Antibodies) in antigen-presenting cells.
This gene encodes a class IV histone deacetylase. The encoded protein is localized to the nucleus and may be involved in regulating the expression of interleukin 10. Alternative splicing results in multiple transcript variants.
, histone deacetylase X
, histone deacetylase 11